Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with cisplatin
and vinorelbine in treating patients with refractory or recurrent squamous cell cervical
cancer that has not responded to local therapy.